HB-EGF INHIBITOR DERIVED FROM THE R DOMAIN OF DIPHTHERIA TOXIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF THE HB-EGF/EGFR PATHWAY
- Application ID: EP13720081
- Status: █ EXAMINATION IN PROGRESS
This EP application has the IPC class A61, C07, C12, and G01. Cabinet Orès is specialized in the combination A61, C07, C12, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Kilburn & Strode LLP, Potter Clarkson LLP and 56 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.